Ideas

Ribonucleic acid-based therapy for Diabetes Mellitus: LncRNA ROR augments the expression of FGF19 and FGF1,  attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIDM, via upregulation of its target gene, 13/March/2019, 10.56 pm
Ribonucleic acid-based therapy for Diabetes Mellitus: LncRNA ROR augments the expression of FGF19 and FGF1,  attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIDM, via upregulation of its target gene, 13/March/2019, 10.56 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say  A study from Diabetes and Obesity Center of Excellence, Department of Medicine, University of Washington, Seattle, Washington, USA shows that Central injection of FGF1 induces sustained…

read more

Ribonucleic acid-based Anti-infective Therapy: LncRNA KCNQ10T1 inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  respiratory syncytial,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 13/March/2019,  10.48  am
Ribonucleic acid-based Anti-infective Therapy: LncRNA KCNQ10T1 inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  respiratory syncytial,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 13/March/2019,  10.48  am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more

Anti-HIV therapy: A pharmaceutical mixture encompassing etoposide and idasanutlin(ESIA) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production, via upregulation of its target gene, 13/March/2019, 10.39 pm
Anti-HIV therapy: A pharmaceutical mixture encompassing etoposide and idasanutlin(ESIA) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production, via upregulation of its target gene, 13/March/2019, 10.39 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Anti-HIV therapy: A pharmaceutical mixture encompassing etoposide and idasanutlin(ESIA) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1…

read more

Ribonucleic acid-based therapy for glaucoma:  LncRNA TUG1  increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against glaucoma,  via down regulation of its target gene, 13/March/2018, 5.26 am
Ribonucleic acid-based therapy for glaucoma:  LncRNA TUG1  increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against glaucoma,  via down regulation of its target gene, 13/March/2018, 5.26 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, USA; The Howard Hughes…

read more

Repurposing the antihyperlipidemic drug Atorvastatin into an anti-HIV agent: Atorvastatin (trade name: Lipitor), a medication prescribed to lower cholesterol and triglyceride, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production, via upregulation of its target gene, 12/March/2019, 9.51 am
Repurposing the antihyperlipidemic drug Atorvastatin into an anti-HIV agent: Atorvastatin (trade name: Lipitor), a medication prescribed to lower cholesterol and triglyceride, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production, via upregulation of its target gene, 12/March/2019, 9.51 am 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Repurposing the antihyperlipidemic drug Atorvastatin into an anti-HIV agent: Atorvastatin (trade name: Lipitor), a medication prescribed to lower cholesterol and triglyceride,…

read more

Probiotic-based immune enhancement therapy: Probiotic Clostridium butyricum MIYAIRI 588 (CBM588) increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene, 12/March/2019, 9.41 am
Probiotic-based immune enhancement therapy: Probiotic Clostridium butyricum MIYAIRI 588 (CBM588) increases SOX2 expression, and promotes innate immunity against bacterial infection, via down-regulation of its target gene, 12/March/2019, 9.41 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:   A recent study from the Institute of Biophysics, Chinese Academy of Sciences, Beijing, China shows that “Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate…

read more
Start Typing